Abstract
Digitoxin is the main cardioactive glycoside in Digitalis purpurea and was purified by Nativelle (1864). Although it was the first cardiac glycoside introduced into clinical medicine, our knowledge of its pharmacokinetics and metabolism originates from research done during the last decades.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amlie, J.P., Storstein, L., Heldaas, O.: Correlation between pharmacokinetics and inotropic and electrophysiologic response to digitoxin in the intact dog. J. Cardiovasc. Pharmacol. 1, 529–540 (1979)
Ashley, J.J., Brown, B.T., Okita, G.T., Wright, S.E.: The metabolites of cardiac glycosides in human urine. J. Biol. Chem. 232, 315–322 (1958)
Beerman, B., Hellström, K., Rosen, A.: Fate of orally administered 3H-digitoxin in man with special reference to absorption. Circulation 43, 852–862 (1971)
Beerman, B., Hellström, K.: The efficacy of lymph drainage in the elimination of orally administered digitoxin and digoxin. Pharmacology 6, 17–21 (1971)
Beller, G.A., Smith, T.W., Abelmann, W.H., Haber, E., Hood, W.B., Jr.: Digitalis intoxication. A prospective clinical study with serum level correlations. N. Engl. J. Med. 284, 989–997 (1971)
Benthe, H.F.: Organverteilung verschiedener Herzglykoside. In: Digitalistherapie, Beiträge zur Pharmakologie. Jahrmärker, H. (ed.), pp. 25–34. Berlin, Heidelberg, New York: Springer 1975
Bentley, J.D., Burnett, G.H., Conklin, R.L., Wassenburger, R.H.: Clinical application of serum digitoxin levels. A simplified plasma determination. Circulation 41, 67–75 (1970)
Bever, R.J. Van, Duchateau, A.M.J.A., Pluym, B.F.M., Merkus, F.W.H.M.: The effect of colestipol on digitoxin plasma levels. Arzneim. Forsch. 26, 1891–1893 (1976)
Bodem, G., Unruh, E. v.: Dihydrodigitoxin, a metabolite of digitoxin in humans. In: Cardiac glycosides, International Boehringer Mannheim Symposia. Bodem, G., Dengler, H.J. (eds.), part 1, pp. 74–84. Berlin, Heidelberg, New York: Springer 1978
Brown, B.T., Ranger, D., Wright, S.E.: The excretory products of lanatoside C and digitoxin in the rat. J. Pharmacol. Exp. Ther. 113, 353–358 (1955)
Caldwell, J.H., Bush, C.A., Greenberger, N.J.: Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man. J. Clin. Invest. 50, 2638–2644 (1971)
Castle, M.C., Lage, G.L.: Metabolism and distribution of digitoxin in the rat. Arch. Int. Pharmacodyn. Ther. 203, 323–334 (1973)
Castle, M.C., Lage, G.L.: Cleavage by ß-glucuronidase of the water-soluble metabolites of digitoxin excreted in the bile of control and spironolactone-pretreated rats. Toxicol. Appl. Pharmacol. 27, 641–647 (1974)
Clark, D.R., Kalman, S.M.: Dihydrodigoxin: a common metabolite of digoxin in man. J. Pharmacol. Exp. Ther. 2, 148–150 (1974)
Croxson, M.S., Ibbertson, H.K.: Serum digoxin in patients with thyroid disease. Brit. Med. J. 1975 III, 566–568
Doherty, J.E., Perkins, W.H.: Digoxin metabolism in hypo-and hyperthyroidism. Studies with tritiated digoxin in thyroid disease. Ann. Int. Med. 64, 489–507 (1966)
Domschke, W., Meinecke, O., Domagk, G.F.: Untersuchungen zum Stoffwechsel des Digitaliszuckers Digitoxose in der Ratte. Naunyn Schmiedebergs Arch. Pharmacol. 265, 149–155 (1969)
Dutta, S., Marks, B.H.: Species and ionic influences on the accumulation of digitalis glycosides by isolated perfused hearts. Brit. J. Pharmacol. 46, 401–408 (1972)
Eickenbusch, W., Lahrtz, H.G., Seppelt, U., Zwieten, P.A. van: Serum concentration and urinary excretion of 3H-ouabain and 3H-digitoxin in patients suffering from hyperthyroidism or hypothyroidism. Klin. Wochenschr. 5, 270–275 (1970)
Finkelstein, F.O., Goeffinet, J.A., Hendler, E.D., Lindenbaum, J.: Pharmacokinetics of digoxin and digitoxin in patients undergoing hemodialysis. Am. J. Med. 58, 525–531 (1975)
Fischer, C.S., Sjoerdsma, A., Johnson, R.: The tissue distribution and excretion of radioactive digitoxin. Circulation 5, 496–503 (1952)
Flasch, H., Heinz, N.: Konzentration von Herzglykosiden im Myokard und im Gehirn. Arzneim. Forsch. 26, 1213–1216 (1976)
Flasch, H., Heinz, N., Petersen, R.: Affinität von polaren Digoxin-und Digitoxin-Metabo- liten zu Digoxin-und Digitoxin-Antikörpern. Arzneim. Forsch. 27, 649–653 (1977)
Forester, W., Lewis, R.P., Weissler, A.M., Wilke, T.A.: The onset and magnitude of the contractile response to commonly used glycosides in normal subjects. Circulation 49, 517–521 (1974)
Friedman, M., St. George, S., Bine, R., Jr.: The behavior and fate of digitoxin in the experimental animal and man. Medicine 33, 15–41 (1954)
Förster, W., Gadke, K.: The uptake and content of digitoxin and its metabolites in the heart muscle in guinea-pigs after acute and chronic application. Biochem. Pharmacol. 16, 1165–1174 (1957)
Gade, J., Zwieten, P.A. van: Vergleichende Untersuchungen am Meerschweinchen über die Serumradioaktivität, die Ausscheidung und die Gewebsverteilung von 3H-Digitoxigenin. Naunyn Schmiedebergs Arch. Pharmacol. 264, 234–235 (1969)
Giardina, A.C.V., Ehlers, K.H., Morrison, J.B., Engle, M.A.: Serum digitoxin concentrations in infants and children. Circulation 51, 713–717 (1975)
Gilfrich, H.J.: Untersuchungen zur Pharmakokinetik von Digoxin bei hyperthyreoten Patienten. Verh. Dtsch. Ges. Inn. Med. 82, 1726–1728 (1976)
Gjerdrum, K.: Digitoxin studies. Acta Med. Scand. 191, 25–35 (1972)
Greeff, K., Hafner, D., Strobach, H., Wirth, K.E.: Vergleich der biologischen Verfügbarkeit und renalen Elimination von Digitoxin und Digoxin. Herz/Kreisl. 11, 221–224 (1979)
Greenberger, N.J., Thomas, F.B.: Biliary excretion of 3H-digitoxin: Modification by bile salts and phenobarbital. J. Lab. Clin. Med. 80, 241–251 (1973)
Griffin, C.L., Pendleton, R., Burstein, S.: Metabolism of cardiac glycosides-II. Cardiotoxicity of metabolites of digitoxin-7. Biochem. Pharmacol. 20, 97–102 (1971)
Herrmann, I., Repke, K.: Über das Glukuronsäurekonjugat eines Cardenolidgenins β-Epidigitoxigenin). Experientia 19, 472–474 (1963)
Herrmann, I., Repke, K.: Entgiftungsgeschwindigkeit und Kumulation von Digitoxin bei verschiedenen Species. Naunyn-Schmiedebergs Arch. Pharmacol. 247,19–34 (1964a)
Herrmann, I., Repke, K.: Speciesunterschiede in der Biotransformation von Digitoxin. Naunyn-Schmiedebergs Arch. Pharmacol. 247,35–48 (1964b)
Herrmann, I., Repke, K.: Konjugation von Cardenolidgeninen mit Schwefelsäure oder Glucuronsäure. Naunyn-Schmiedebergs Arch. Pharmacol. 248, 370–386 (1964c)
Herrmann, I., Repke, K.: Epimerisierung und Hydroxylierung von digitaloiden Steroidlactonen durch Fermente der Leber. Naunyn-Schmiedebergs Arch. Pharmacol. 248, 351–369 (1964)
Ingwersen, F.: The pharmacokinetics of 3H-digitoxin and its metabolites in the guinea-pig. Naunyn-Schmiedebergs Arch. Pharmacol. 282 (Suppl. R): 38 (1974)
Izumi, T., Fujino, S., Yorozuya, S., Tanaka, M.: Accumulation of digitoxin by the heart and “the cumulative effect of digitalis.” Jap. J. Pharmacol. 18, 269–270 (1968)
Katzung, B.G., Meyers, F.H.: Excretion of radioactive digitoxin by the dog. J. Pharmacol. Exp. Ther. 149, 257–262 (1965)
Katzung, B.G., Meyers, F.H.: Biotransformation of digitoxin in the dog. J. Pharmacol. Exp. Ther. 154, 575–580 (1966)
Klaassen, C.D.: Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides. J. Pharmacol. Exp. Ther. 191, 201–211 (1974)
Kokenge, F., Jost, S., Kolenda, K.-D.: Vergleichende Untersuchung über die Serumspiegel von Digoxin und Digitoxin bei eingeschränkter Nierenfunktion. Therapiewoche 28, 1032–1036 (1978)
Kolenda, K.-D., Ullmann, H., Peters, T.: Metabolism of cardiac glycosides studies in the isolated perfused guinea-pig liver. Brit. J. Pharmacol. 41, 661–673 (1971)
Kramer, P., Horenkamp, J., Willms, B., Scheler, F.: Das Kumulationsverhalten verschiedener Herzglykoside bei Anurie. Dtsch. Med. Wochenschr. 95, 444–454 (1970)
Kramer, P.: Digitalis pharmacokinetics and therapy with respect to impaired renal function. Klin. Wochenschr. 55, 1–11 (1977)
Krasula, R.W., Hastreiter, A.R., Levitsky, S., Yanagi, R., Soyka, L.F.: Serum, atrial, and urinary digoxin levels during cardiopulmonary bypass in children. Circulation 49, 1047–1052 (1974)
Kuhlmann, J., Abshagen, U., Rietbrock, N.: Cleavage of glycoside bonds of digoxin derivatives as function of pH and time. Naunyn-Schmiedebergs Arch. Pharmacol. 276, 149–256 (1973)
Kuhlmann, J., Abshagen, U., Rietbrock, N.: Pharmacokinetics and metabolism of digitoxigenin-mono-digitoxoside in man. Eur. J. Clin. Pharmacol. 7, 87–94 (1974)
Kuhlmann, J., Rietbrock, N., Schnieders, B.: Tissue distribution of cardiac glycosides. In: Cardiac glycosides. International Boehringer Mannheim Symposia. Bodem, G., Dengler, H.J. (eds.), part 1, pp. 109–119. Berlin, Heidelberg, New York: Springer 1978
Lahrtz, H.G., Reinold, H.M., Zwieten, P.A., van: Serum-Konzentration und Ausscheidung von 3H-Digitoxin beim Menschen unter normalen und pathologischen Bedingungen. Klin. Wochenschr. 47, 695–700 (1969)
Larsen, A., Storstein, L.: Protein binding and pharmacokinetics of digitoxin in children. VIII World Congress of Cardiology, Tokyo, September 1978. Abstracts-I, p. 419. Ciba-Geigy Ltd., Basel
Lauterbach, F.: Enterale Resorption, biliäre Ausscheidung und enterohepatischer Kreislauf von Herzglykosiden bei der Ratte. Naunyn-Schmiedebergs Arch. Pharmacol. 247, 391–411 (1964)
Lauterbach, F., Repke, K.: Über die Verteilung herzglykosidspaltender Fermente im tieri- schen Organismus. Naunyn-Schmiedebergs Arch. Pharmacol. 240, 45–71 (1969)
Lawrence, J.R., Sumner, D.J., Kalk, W.J., Ratcliffe, W.A., Whiting, B., Gray, K., Lindsay, M.: Digoxin kinetics in patients with thyroid dysfunction. Clin. Pharmacol. Ther. 22, 7–14 (1977)
Lukas, D.S.: Some aspects of the distribution and disposition of digitoxin in man. Ann. N.Y. Acad. Sci. 179, 338–362 (1971)
Lukas, D.S.: Pharmacokinetics and metabolism of digitoxin in man. In: Symposium on digitalis. Storstein, O. (ed.), pp. 84–102. Oslo: Gyldendal Norsk Forlag 1973
Lukas, D.S., Peterson, R.E.: Double isotope dilution derivative assay of digitoxin in plasma, urine, and stools of patients maintained on the drug. J. Clin. Invest. 45, 782–796 (1966)
Lüllmann, H., Peters, T., Zwieten, P.A. van: The distribution of 3H-labeled cardenolides between isolated guinea-pig atrial tissue and circulating, oxygenated whole blood. Brit. J. Pharmacol. 36, 276–285 (1969)
Marzo, A., Ghirardi, P., Prett, A., Lombardo, A., Longhini, C., Musacci, G.: Subcellular distribution of deslanatoside C, ouabain, and digitoxin in the heart and liver of conscious guinea pigs. Biochem. Pharmacol. 26, 2427–2431 (1977)
Morrison, J., Killip, T.: Radioimmunoassay of digitoxin. Clin. Res. 18, 668 (1970)
Myhre, E., Storstein, L., Amlie, J.P.: Studies on digitalis. 16. Malabsorption of digitoxin in severely symptomatic patients with sprue and dumping syndrome after gastrectomy. Submitted for publication Nativelle, C.A.: Sur la digitaline cristallisée. J. Pharm. (Lond.) 9, 255 (1864)
Okita, G.T.: Studies with radioactive digitalis. J. Am. Geriatr. Soc. 5, 163–175 (1957)
Okita, G.T.: Species difference in duration of action of cardiac glycosides. Fed. Proc. 26, 1125–1130 (1967)
Okita, G.T., Kelsey, F.E., Talso, P.J., Smith, L.B., Geiling, E.M.K.: Studies on the renal excretion of radioactive digitoxin in human subjects with cardiac failure. Circulation 7, 161–168 (1953)
Okita, G.T., Plotz, E.J., Davis, M.E.: Placental transfer of radioactive digitoxin in pregnant women and its fetal distribution. Circulation 9, 376–380 (1956)
Okita, G.T., Talso, P.J., Curry, J.H., Smith, F.D., Geiling, E.M.K.: Blood level studies of 14C-digitoxin in human subjects with cardiac failure. J. Pharmacol. Exp. Ther. 113, 376–383 (1955a)
Okita, G.T., Talso, P.J., Curry, J.C., Smith, F.D., Geiling, E.M.K.: Metabolic fate of radio- active digitoxin in human subjects. J. Pharmacol. Exp. Ther. 115, 371–379 (1955b)
Oliver, G.Ch., Santinin, L.A., Griffin, G., Ruffy, R.: Enterohepatic circulation of digitoxin metabolites in the dog. In: Cardiac glycosides. Internation. Boehringer Mannheim Symposia, Bodem, G., Dengler, H.J. (eds.), part 1, pp. 85–93. Berlin, Heidelberg, New York: Springer 1978
Peters, U., Hausamen, T.-U., Grosse-Brockhoff, F.: Therapie mit Digitoxin unter Kontrolle des Serum-Digitoxinspiegels. Dtsch. Med. Wochenschr. 99, 1701–1701 (1974)
Peters, U., Grabensee, B., Hausamen, T.-U., Fritsch, W.P., Grosse-Brockhoff, F.: Pharmakokinetik von Digitoxin bei chronischer Niereninsuffizienz. Dtsch. Med. Wochenschr. 102, 109–115 (1977)
Rasmussen, K., Jervell, J., Storstein, L., Gjerdrum, K.: Digitoxin kinetics in patients with impaired renal function. Clin. Pharmacol. Ther. 13, 6–15 (1972)
Rasmussen, K., Jervell, J., Storstein, O.: Clinical use of bioassay of serum digitoxin activity. Eur. J. Pharmacol. 3, 236–252 (1971)
Repke, K.: Verteilung, Ausscheidung und Stoffwechsel von Digitoxin bei der Ratte. Naunyn-Schmiedebergs Arch. Pharmacol. 233, 271–283 (1958)
Repke, K.: Die Bis-und Mono-digitoxoside des Digitoxigenins und Digoxigenins. Metaboliten des Digitoxins. Naunyn-Schmiedebergs Arch. Pharmakol. 237, 155–170 (1959)
Repke, K., Samuels, L.T.: Enzymatic basis for epimerization of cardiotonic steroids at carbon 3 in rat liver. Biochemistry 3, 689–695 (1964)
Rietbrock, N., Vöhringer, H.F.: Metabolism and excretion of 3H-digitoxin in the rat. Biochem. Pharmacol. 23, 2567–2575 (1974)
Shenfield, G.M., Thompson, J., Horn, D.B.: Plasma and urinary digoxin in thyroid dysfunction. Eur. J. Clin. Pharmacol. 12, 437–443 (1977)
Steiness, E., Valentin, N.: Myocardial digoxin uptake: Dissociation between digitalis-induced inotropism and myocardial loss of potassium. Brit. J. Pharmacol. 58, 183–188 (1976)
Stoll, R.G., Christensen, M.S., Sakmar, E., Blair, D., Wagner, J.G.: Determination of bio-availability of digitoxin using the radioimmunoassay procedure. J. Pharm. Sci. 62, 1615–1620 (1973)
Storstein, L.: The influence of renal function on the pharmacokinetics of digitoxin. In: Symposium on digitalis. Storstein, O. (ed.), pp. 158–168. Oslo: Gyldendal Norsk Forlag 1973
Storstein, L.: Studies on digitalis. I. Renal excretion of digitoxin and its cardioactive metabolites. Clin. Pharmacol. Ther. 16, 14–24 (1974a)
Storstein, L.: Studies on digitalis. II. The influence of impaired renal function on the renal excretion of digitoxin and its cardioactive metabolites. Clin. Pharmacol. Ther. 16, 25–34 (1974b)
Storstein, L.: Studies on digitalis. III. Biliary excretion and enterohepatic circulation of digi- toxin and its cardioactive metabolites. Clin. Pharmacol. Ther. 17, 313–320 (1975)
Storstein, L.: Studies on digitalis. V. The influence of impaired renal function, hemodialysis, and drug interaction on serum protein binding of digitoxin and digoxin. Clin. Pharmacol. Ther. 20, 6–14 (1976a)
Storstein, L.: Studies on digitalis. VII. The influence of nephrotic syndrome on protein binding, pharmacokinetics, and renal excretion of digitoxin and cardioactive metabolites. Clin. Pharmacol. Ther. 20, 158–166 (1976b)
Storstein, L.: Studies on digitalis. VIII. Digitoxin metabolism on a maintenance regimen and after a single dose. Clin. Pharmacol. Ther. 21, 125–140 (1977a)
Storstein, L.: Studies on digitalis. X. Digitoxin metabolites in human myocardium and relationship between myocardial and serum concentrations of digitoxin in patients on maintenance treatment. Clin. Pharmacol. Ther. 21, 395–408 (1977b)
Storstein, L.: Studies on digitalis. XI. Digitoxin metabolism in patients with impaired renal function. Clin. Pharmacol. Ther. 21, 536–546 (1977c)
Storstein, L., Amlie, J.P.: Studies on digitalis. IX. Some kinetic aspects of digitoxin metabolism. Clin. Pharmacol. Ther. 21, 255–266 (1977a)
Storstein, L., Amlie, J.P.: Studies on digitalis. XII. Kinetic pattern of digitoxin metabolism in patients with biliary fistulas. Clin. Pharmacol. Ther. 21,659–674 (1977b)
Storstein, L.: Digitoksin i klinisk bruk. T. norske Legeforen. Hjerte-Karsykdommer i praksis 22, 23–30 (1979a)
Storstein, L., Amlie, J.P.: Pharmacokinetics and metabolism in patients with chronic active hepatitis. In: Digitoxin als Alternative in der Therapie der Herzinsuffizienz. Rietbrock, N., Greeff, K. (eds.), pp. 191–199. Frankfurt, 1978. München: Schattauer 1979
Storstein, L., Jonsgard, M.: Studies on digitalis. 15. Bioavailability of digitoxin. Acta Med. Scand. Suppl. 645, 91–95 (1981)
Storstein, L., Nore, A.-K., Sjaastad, O.: Studies on digitalis. 23. Blood-brain barrier of digitoxin in humans. Clin. Cardiol. 2, 146–150 (1979)
Storstein, L.: Why thyrotoxic patients need increased doses of digitoxin. Suppl. Circulation. 60-II-182 (1979)
Storstein, L., Larsen, A., Midtbö, K.: Is old age a risk factor for digitoxin intoxication? VIII European Congress of Cardiology, Paris, June 1980, p. 204, published by Sandoz, Basel
Storstein, O., Hansteen, V., Hatle, L., Hillestad, L., Storstein, L.: Studies on digitalis. XIII. A prospective study of 649 patients on maintenance treatment with digitoxin. Am. Heart J. 93, 434–443 (1977)
Takanashi, T., Katoh, T., Takeda, H., Tokuoka, T., Hamamoto, H., Kitamura, K.: The absorption of digitoxin in patients with acute and chronic diarrhea. Jpn. Circ. J. 42, 849–853 (1978)
Vöhringer, H.F., Rietbrock, N.: Metabolism and excretion of digitoxin in man. Clin. Pharmacol. Ther. 16, 796–806 (1974)
Vöhringer, H.F., Rietbrock, N., Spurny, P., Kuhlmann, J, Hampl, H., Baethke, R.: Disposition of digitoxin in renal failure. Clin. Pharmacol. Ther. 19, 387–395 (1976)
Vöhringer, H.F., Weller, L., Rietbrock, N.: Influence of spironolactone pretreatment on pharmacokinetics and metabolism of digitoxin in rats. Naunyn-Schmiedebergs Arch. Pharmacol. 287, 129–139 (1975)
Vöhringer, H.F., Wogenstein, J.-M., Rietbrock, N.: Die biologische Verfügbarkeit von Digitoxin. Fortschr. Med. 95, 2323–2325 (1977)
Wirth, K.E., Frölich, J.C., Hollefield, J.W., Falkner, F.C., Sweetman, B.S., Oates, J.A.: Metabolism of digitoxin in man and its modification by spironolactone. Eur. J. Clin. Pharmacol. 9, 345–3 54 (1976)
Wright, S.E.: The metabolism of cardiac glycosides. Springfield, Ill.: Charles C. Thomas 1960
Zilly, W., Frank, P., Richter, E., Rietbrock, N.: Die Elimination von Digitoxin bei Leberkrankheiten. Verh. Dtsch. Ges. Inn. Med. 82, 1663–1666 (1976)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Storstein, L. (1981). Pharmacokinetics of Digitoxin. In: Greeff, K. (eds) Cardiac Glycosides. Handbook of Experimental Pharmacology, vol 56 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68166-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-68166-0_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68168-4
Online ISBN: 978-3-642-68166-0
eBook Packages: Springer Book Archive